/PRNewswire/ AtriAN Medical today announced that it has completed enrollment of a second study using its selective pulsed field ablation (PFA) technology.
/PRNewswire/ Irish medical device company AtriAN Medical today announced that clinical data from it s first-in-human study was presented at this years.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Positive Preliminary Clinical Trial Results Reported for Vascular Dynamics’ Novel Heart Failure Treatment Technology
February 9, 2021 GMT
IRVINE, Calif. (BUSINESS WIRE) Feb 9, 2021
Vascular Dynamics, Inc., a privately held medical device company focused on innovative, endovascular device-based solutions for cardiovascular conditions, has announced positive preliminary results from its clinical trial, “A Feasibility Study Exploring the Effect of the MobiusHD ® Device in Patients with Heart Failure.”
ADVERTISEMENT
Horst Sievert, MD, Director of the CardioVascular Center in Frankfurt, Germany, and Tamaz Shaburishvili, MD, Head of the Cardiovascular Clinic at Tbilisi Heart and Vascular Clinic in Tbilisi, Georgia, shared preliminary results of the clinical trial as part of a CSI Focus D-HF webinar presented last week.